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The main goal of this dissertation was to explore new protocols to synthesize biocompatible radioactive
gold nanoparticles to treat and image cancer and calculate the dose distribution by using MCNP in tumor
inside the human prostate as well as surrounding normal tissues.
This dissertation  is classified into three  projects. The objective of the first project is production and
evaluation of radioactive MGF-198AuNPs and MGF-199AuNPs towards prostate cancer treatment and
imaging. Non-radioactive MGF-AuNPs  were synthesized first and in vitro evaluated.  Results of In vitro
evaluation showed that this type of nanoparticles is stable, non toxic, and can be internalized into prostate
cancer cells. Next, new modified protocols were devloped to produce radioactive MGF-198AuNPs and
MGF-199AuNPs.  UV-Vis spectroscopy and TLC measurements showed that these radioactive MGF-
198AuNPs and MGF-199AuNPs  are stable and more than 96% of radioactive gold was within
nanoparticlate structure. Then, MGF-198AuNPs were in vivo evaluated to investigate their in vivo stability,
retention in tumor, and efficacy to cure prostate cancer. The results indicated that MGF-198AuNPs are
stable and have excellent ability to be retained within the tumor up to 24 hours with very minimum leakage
to non-target organs.  It was also found that radioactive MGF-198AuNPs have significant therapeutic effect
and that they were able to control the tumor size in comparison to control group. 
The objective of the second project is production and evaluation of radioactive citrate-199AuNPs as
imaging probe for single photon emission computed tomography. In this study, a new protocol was
developed to synthesize radioactive citrate-199AuNPs, UV-Vis spectroscopy and TLC measurements
showed that new protocol was successful to produce stable radioactive citrate-199AuNPs. Also, In vivo
evaluation results showed that citrate-199AuNPs are stable in vivo and therfore, they can be used in
imaging procedures.
The objective of the third project is estimation, by means of MCNP simulations, the dose distribution
delivered by radioactive gold nanoparticles (198AuNPs or199AuNPs) to tumor inside the human prostate
as well as to the normal tissues surrounding the tumor, using water and A-150 tissue equivalent plastic
phantoms. A simple geometrical model of a human prostate was used, and the dose distribution that is
deposited by radioactive gold nanoparticles (198AuNPs or 199AuNPs) was calculated using MCNP. The
results showed that the deposited dose by 198AuNPs or 199AuNPs, which are distributed homogenously in
the tumor, has maximum value at the tumor region and then decreases toward the normal tissue in the
prostate as well as surrounding organs. However, the dose deposited by 198Au is significantly higher than
the dose deposited by 199Au at the tumor region as well as normal tissues. Therefore 198Au should be
preferred to for therapeutic applications, while should be preferred for 199Au in imaging applications. 
